根据提供的文档内容，该文档不包含任何关于公司或行业的实质性信息 无法完成新闻要点总结任务 [1]

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is a global leader in musculoskeletal healthcare. The company designs, manufactures, and markets orthopedic reconstructive products, including knee and hip replacements, as well as other surgical and dental products. Zimmer Biomet competes with other major players in the medical device industry, such as Stryker Corporation and Johnson & Johnson.On November 5, 2025, Rick Wise from Stifel Nicolaus set a price target of $110 for ZBH. At that time, the stock was trading a ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...